Transcription of ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
{{id}} {{{paragraph}}}
Example: biology
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 This medicinal PRODUCT is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT Paxlovid 150 mg + 100 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each pink film-coated tablet contains 150 mg of PF-07321332*. Each white film-coated tablet contains 100 mg of ritonavir. * PF-07321332 corresponds to the substance with the chemical name: (1R,2S,5S)-N-((1S)-1-Cyano-2-((3S)-2-oxo pyrrolidin-3-yl)ethyl)-3-((2S)-3,3-dimet hyl-2-(2,2,2-trifluoroacetamido)butanoyl )-6,6-dimethyl-3-azabicyclo[ ]hexane-2-carboxamide.
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. 2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: